Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Leavey, Katherine ^a   Bainbridge, Shannon A ^b   Cox, ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER;

ARTICLE; BIOINFORMATICS; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; MICROARRAY ANALYSIS; MOLECULAR GENETICS; OXYGENATION; PREECLAMPSIA; PREGNANCY; BIOLOGY; CLASSIFICATION; CLUSTER ANALYSIS; FEMALE; GENETICS; METABOLISM; PROCEDURES;

BIOMARKERS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MICROARRAY ANALYSIS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84923064464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116508     Document Type: Article

References (59)

1. Vigil-De Gracia P (2009) Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynaecol Obstet 104: 90-94. doi: 10.1016/j.ijgo.2008.09.014 PMID: 19027902
2. Wallis AB, Saftlas AF, Hsia J, Atrash HK (2008) Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 21: 521-526. doi: 10.1038/ajh.2008.20 PMID: 18437143
3. Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683. doi: 10.1056/NEJMoa031884 PMID: 14764923
4. Kleinrouweler CE, Wiegerinck MMJ, Ris-Stalpers C, Bossuyt PMM, van der Post J a M, et al. (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 119: 778-787. doi: 10.1111/j.1471-0528.2012.03311.x PMID: 22433027
5. Cnossen J, Morris R, ter Riet G, Mol B, van der Post J, et al. (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178: 1-11.
6. Tsai S, Hardison NE, James A, Motsinger-Reif A, Bischoff SR, et al. (2011) Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 32: 175-182. doi: 10.1016/j.placenta.2010.11.014 PMID: 21183218
7. Kleinrouweler CE, van Uitert M, Moerland PD, Ris-Stalpers C, van der Post J a M, et al. (2013) Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLoS One 8: e68991. doi: 10.1371/journal.pone.0068991 PMID: 23874842
8. Vaiman D, Calicchio R, Miralles F (2013) Landscape of transcriptional deregulations in the preeclamptic placenta. PLoS One 8: e65498. doi: 10.1371/journal.pone.0065498 PMID: 23785430
9. Cox B, Sharma P, Evangelou AI, Whiteley K, Ignatchenko V, et al. (2011) Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics 10: M111.012526. doi: 10.1074/mcp.M111.012526 PMID: 21986993
10. Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51: 970-975. doi: 10.1161/HYPERTENSIONAHA.107.107607 PMID: 18259009
11. Roberts JM, Bell MJ (2013) If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol. doi: 10.1016/j.jri.2013.05.003 PMID: 25622880
12. Von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. Hypertens Pregnancy 22: 143-148. doi: 10.1081/PRG-120021060 PMID: 12908998
13. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101: 811-816. doi: 10.1073/pnas.0304146101 PMID: 14711987
14. Van 't Veer LJ, Dai H, van de Vijver MJ, He YD, AM HA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536. doi: 10.1038/415530a PMID: 11823860
15. Heider A, Alt R (2013) virtualArray: a R/bioconductor package to merge raw data from different microarray platforms. BMC Bioinformatics 14: 75. doi: 10.1186/1471-2105-14-75 PMID: 23452776
16. Blair JD, Yuen RKC, Lim BK, McFadden DE, von Dadelszen P, et al. (2013) Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod 19: 697-708. doi: 10.1093/molehr/gat044 PMID: 23770704
17. Meng T, Chen H, Sun M, Wang H, Zhao G, et al. (2012) Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS 16: 301-311. doi: 10.1089/omi.2011.0066 PMID: 22702245
18. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, et al. (2011) Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 9: 107. doi: 10.1186/1477 -7827-9-107 PMID: 21810232
19. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, et al. (2007) Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 28: 487-497. doi: 10.1016/j.placenta.2006.05.010 PMID: 16860862
20. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen T a, et al. (2009) Differential placental gene expression in severe preeclampsia. Placenta 30: 424-433. doi: 10.1016/j.placenta.2009.01.012 PMID: 19249095
21. Xiang Y, Cheng Y, Li X, Li Q, Xu J, et al. (2013) Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia. PLoS One 8: e59753. doi: 10.1371/journal.pone.0059753 PMID: 23544093
22. Buckberry S, Bianco-Miotto T, Bent SJ, Dekker G a, Roberts CT (2014) Integrative transcriptome metaanalysis reveals widespread sex-biased gene expression at the human fetal-maternal interface. Mol Hum Reprod 0: 1-10. doi: 10.1093/molehr/gau035
23. Lee KJ, Shim SH, Kang KM, Kang JH, Park DY, et al. (2010) Global gene expression changes induced in the human placenta during labor. Placenta 31: 698-704. doi: 10.1016/j.placenta.2010.05.006 PMID: 20554320
24. Mayhew T (2008) Taking tissue samples from the placenta: an illustration of principles and strategies. Placenta 29: 1-14. PMID: 17658596
25. Yuen RKC, Robinson WP (2011) Review: A high capacity of the human placenta for genetic and epigenetic variation: Implications for assessing pregnancy outcome. Placenta: 6-11. doi: 10.1016/j.placenta.2011.01.003
26. Bainbridge SA, Minhas A, Whiteley KJ, Qu D, Sled JG, et al. (2012) Effects of Reduced Gcm1 Expression on Trophoblast Morphology, Fetoplacental Vascularity, and Pregnancy Outcomes in Mice. Hypertension 59: 732-739. doi: 10.1161/HYPERTENSIONAHA.111.183939 PMID: 22275534
27. Kulandavelu S, Whiteley KJ, Bainbridge SA, Qu D, Adamson SL (2013) Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice. Hypertension 61: 259-266. doi: 10.1161/HYPERTENSIONAHA.112.201996 PMID: 23150513
28. Wang A, Rana S, Karumanchi SA (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24: 147-158. doi: 10.1152/physiol.00043.2008 PMID: 19509125
29. Myatt L (2002) Role of placenta in preeclampsia. Endocrine 19: 103-111. doi: 10.1385/ENDO:19:1:103 PMID: 12583607
30. Rademacher TW, Gumaa K, Scioscia M (2007) Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder? J Reprod Immunol 76: 78-84. doi: 10.1016/j.jri.2007.03.019 PMID: 17537518
31. Antonios TFT, Nama V, Wang D, Manyonda IT (2013) Microvascular remodelling in preeclampsia: quantifying capillary rarefaction accurately and independently predicts preeclampsia. Am J Hypertens 26: 1162-1169. doi: 10.1093/ajh/hpt087 PMID: 23757401
32. Ruano R, Fontes RS, Zugaib M (2005) Prevention of preeclampsia with low-dose aspirin - a systematic review and meta-analysis of the main randomized controlled trials. Clinics (Sao Paulo) 60: 407-414. doi: doi:/S1807-59322005000500010
33. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, et al. (2010) Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 362: 1282-1291. doi: 10.1056/NEJMoa0908056 PMID: 20375405
34. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, et al. (2013) Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One 8: e62140. doi: 10.1371/journal.pone.0062140 PMID: 23671584
35. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ (2010) Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122: 478-487. doi: 10.1161/CIRCULATIONAHA.109.895458 PMID: 20644016
36. Corrêa RRM, Gilio DB, Cavellani CL, Paschoini MC, Oliveira F a, et al. (2008) Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 277: 201-206. doi: 10.1007/s00404-007-0452-z PMID: 17786461
37. Tan EK, Tan EL (2013) Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol 27: 791-802. doi: 10.1016/j.bpobgyn.2013.08.001 PMID: 24012425
38. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, et al. (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28: 1248-1250. doi: 10.1038/nbt1210-1248 PMID: 21139605
39. Maglott D, Ostell J, Pruitt KD, Tatusova T (2005) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33: D54-D58. doi: 10.1093/nar/gki031 PMID: 15608257
40. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, et al. (2009) Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 5: e1000427. doi: 10.1371/journal.ppat.1000427 PMID: 19436702
41. Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, et al. (2008) Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod 23: 709-715. doi: 10.1093/humrep/dem404 PMID: 18184644
42. McDonnold M, Dunn H, Hester A, Pacheco LD, Hankins GD V, et al. (2014) High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol 210: 138.e1-e5. doi: 10.1016/j.ajog.2013.09.040 PMID: 24096182
43. Arechavaleta-Velasco F, Ma Y, Zhang J, McGrath CM, Parry S (2006) Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am J Pathol 168: 1951-1959. doi: 10.2353/ajpath.2006.050781 PMID: 16723710
44. Von Dadelszen P, Magee LA, Krajden M, Alasaly K (2003) Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 110: 725-730. PMID: 12892683
45. Gleicher N (2007) Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol 196: 5.e1-e7. doi: 10.1016/j.ajog.2006.09.016
46. Dekker G (2002) The partner's role in the etiology of preeclampsia. J Reprod Immunol 57: 203-215. doi: 10.1016/S0165-0378(02)00039-6 PMID: 12385843
47. Szekeres-Bartho J (n.d.) Immunological relationship between the mother and the fetus. Int Rev Immunol 21: 471-495.
48. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, et al. (2009) Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39. doi: 10.1111/j.1365-2567.2008.03019.x PMID: 19368562
49. Hunt J, Fishback J (1988) Expression of class I HLA genes by trophoblast cells. Analysis by in situ hybridization. J Immunol 140: 1293-1299. PMID: 2449500
50. Constantin CM, Masopust D, Gourley T, Grayson J, Strickland OL, et al. (2007) Normal Establishment of Virus-Specific Memory CD8 T Cell Pool following Primary Infection during Pregnancy. J Immunol 179: 4383-4389. doi: 10.4049/jimmunol.179.7.4383 PMID: 17878333
51. Jordan JA, Huff D, Deloia JA, Jordan JA, Huff D (2001) Placental Cellular Immune Response in Women Infected with Human Parvovirus B19 during Pregnancy Placental Cellular Immune Response in Women Infected with Human Parvovirus B19 during Pregnancy. 8. doi: 10.1128/CDLI.8.2.288 PMID: 11238210
52. Carreiras M, Montagnani S, Layrisse Z (2002) Preeclampsia: A Multifactorial Disease Resulting from the Interaction of the Feto-maternal HLA Genotype and HCMV Infection. Am J Reprod Immunol 48: 176-183. doi: 10.1034/j.1600-0897.2002.01076.x PMID: 12443029
53. Vinnars M- T, Wijnaendts LCD, Westgren M, Bolte AC, Papadogiannakis N, et al. (2008) Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension 51: 1295-1299. doi: 10.1161/HYPERTENSIONAHA.107.104844 PMID: 18362224
54. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41: D991-D995. doi: 10.1093/nar/gks1193 PMID: 23193258
55. Fraley C, Raftery AE (2007) Model-based methods of classification: using the mclust software in chemometrics. J Stat Softw 18: 1-13.
56. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102: 15545-15550. PMID: 16199517
57. Merico D, Isserlin R, Stueker O, Emili A, Bader GD (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984. doi: 10.1371/journal.pone.0013984 PMID: 21085593
58. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, R. Irizarry WH, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer. pp. 397-420.
59. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, et al. (2009) The WEKA Data Mining Software: An Update. SIGKDD Explor 11: 10-18.